BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12556396)

  • 1. Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epithelium.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2003 Feb; 44(2):658-64. PubMed ID: 12556396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD95 ligand expression on corneal epithelium and endothelium influences the fates of orthotopic and heterotopic corneal allografts in mice.
    Osawa H; Maruyama K; Streilein JW
    Invest Ophthalmol Vis Sci; 2004 Jun; 45(6):1908-15. PubMed ID: 15161857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of recipient epithelium in promoting survival of orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):720-6. PubMed ID: 11222533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
    Yamada J; Streilein JW
    Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune privilege and immunogenicity reside among different layers of the mouse cornea.
    Hori J; Joyce NC; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):3032-42. PubMed ID: 10967061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of orthotopic corneal allografts in eyes that cannot support anterior chamber-associated immune deviation induction.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2176-85. PubMed ID: 7558710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunologic mechanisms of corneal allografts reconstituted from cultured allogeneic endothelial cells in an immune-privileged site.
    Hayashi T; Yamagami S; Tanaka K; Yokoo S; Usui T; Amano S; Mizuki N
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3151-8. PubMed ID: 19255161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cell-mediated immune responses elicited by orthotopic corneal allografts in mice.
    Sonoda Y; Sano Y; Ksander B; Streilein JW
    Invest Ophthalmol Vis Sci; 1995 Feb; 36(2):427-34. PubMed ID: 7843911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice.
    Hori J; Streilein JW
    Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1820-8. PubMed ID: 11431448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACAID induced by allogeneic corneal tissue promotes subsequent survival of orthotopic corneal grafts.
    Sonoda A; Sonoda Y; Muramatu R; Streilein JW; Usui M
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):790-8. PubMed ID: 10711695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of orthotopic corneal allografts in C57BL/6 mice.
    Yamada J; Streilein JW
    Transpl Immunol; 1998 Sep; 6(3):161-8. PubMed ID: 9848222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epithelium-deficient corneal allografts display immune privilege beneath the kidney capsule.
    Hori J; Joyce N; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):443-52. PubMed ID: 10670474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of donor-specific ACAID can prolong orthotopic corneal allograft survival in "high-risk" eyes.
    Sano Y; Okamoto S; Streilein JW
    Curr Eye Res; 1997 Nov; 16(11):1171-4. PubMed ID: 9395779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 1 receptor antagonist suppresses allosensitization in corneal transplantation.
    Yamada J; Dana MR; Zhu SN; Alard P; Streilein JW
    Arch Ophthalmol; 1998 Oct; 116(10):1351-7. PubMed ID: 9790635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice.
    Sano Y; Ksander BR; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):53-6. PubMed ID: 8762011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunobiology of xenogeneic cornea grafts in mouse eyes. I. Fate of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes.
    Tanaka K; Yamada J; Joyce N; Streilein JW
    Transplantation; 2000 Feb; 69(4):610-6. PubMed ID: 10708119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of donor-specific cytotoxic T cells in rejection of corneal allografts in normal and high-risk eyes.
    Ksander BR; Sano Y; Streilein JW
    Transpl Immunol; 1996 Mar; 4(1):49-52. PubMed ID: 8762010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunobiology of xenogeneic cornea grafts in mouse eyes. II. Immunogenicity of xenogeneic cornea tissue grafts implanted in anterior chamber of mouse eyes.
    Tanaka K; Streilein JW
    Transplantation; 2000 Feb; 69(4):616-23. PubMed ID: 10708120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.